AlphaStar Capital Management LLC Grows Position in Humana Inc. (NYSE:HUM)

AlphaStar Capital Management LLC grew its position in shares of Humana Inc. (NYSE:HUM) by 96.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 1,257 shares of the insurance provider’s stock after buying an additional 617 shares during the period. AlphaStar Capital Management LLC’s holdings in Humana were worth $470,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC raised its position in shares of Humana by 0.6% in the second quarter. Allspring Global Investments Holdings LLC now owns 624,282 shares of the insurance provider’s stock worth $233,263,000 after acquiring an additional 3,489 shares during the period. Catalyst Financial Partners LLC acquired a new stake in Humana in the second quarter valued at approximately $213,000. Capital Advisors Ltd. LLC increased its position in shares of Humana by 17.0% in the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after buying an additional 31 shares in the last quarter. Independence Bank of Kentucky increased its position in shares of Humana by 18.0% in the second quarter. Independence Bank of Kentucky now owns 1,485 shares of the insurance provider’s stock valued at $555,000 after buying an additional 226 shares in the last quarter. Finally, Banque Pictet & Cie SA raised its stake in shares of Humana by 7.2% during the 2nd quarter. Banque Pictet & Cie SA now owns 16,860 shares of the insurance provider’s stock worth $6,300,000 after buying an additional 1,132 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently issued reports on HUM. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a research note on Monday, August 19th. Piper Sandler started coverage on Humana in a research note on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price objective on the stock. Deutsche Bank Aktiengesellschaft raised their target price on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Morgan Stanley initiated coverage on Humana in a research report on Monday, June 24th. They issued an “equal weight” rating and a $374.00 target price on the stock. Finally, Oppenheimer raised their price target on Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. Thirteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $396.35.

Humana Trading Down 0.8 %

Shares of HUM traded down $2.80 during mid-day trading on Tuesday, hitting $350.20. The company had a trading volume of 201,957 shares, compared to its average volume of 1,647,969. The company has a quick ratio of 1.67, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The business’s 50-day simple moving average is $367.67 and its 200-day simple moving average is $346.48. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The stock has a market cap of $42.20 billion, a PE ratio of 21.98, a P/E/G ratio of 2.09 and a beta of 0.51.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same period in the prior year, the company posted $8.94 EPS. The business’s revenue was up 10.4% compared to the same quarter last year. Sell-side analysts forecast that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.01%. Humana’s dividend payout ratio (DPR) is 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.